Ovintiv director sells $210,028 worth of stock

DENVER—Steven W. Nance, a director at Ovintiv Inc. (NYSE:OVV), has recently sold 5,501 shares of the company’s common stock. The transaction took place on June 4, 2025, at a price of $38.18 per share, amounting to a total sale value of $210,028. Following this transaction, Nance holds 36,632 shares of Ovintiv. The sale was executed directly by Nance, as per the latest SEC filing. The company maintains a strong financial profile with a "GOOD" Financial Health score and has maintained dividend payments for 53 consecutive years. InvestingPro subscribers can access detailed insider trading patterns and comprehensive financial analysis in the Pro Research Report, available for over 1,400 US stocks.

In other recent news, Ovintiv Inc. has seen several noteworthy developments. Fitch Ratings revised its outlook for the company to positive, affirming its Long-Term Issuer Default Ratings at ’BBB-’. This change is attributed to Ovintiv’s progress in debt reduction and recent strategic acquisitions, such as the Montney and Permian transactions, which have enhanced its business profile. Fitch expects Ovintiv to make significant strides toward its long-term debt target of $4 billion over the next 12-18 months.

Evercore ISI adjusted its price target for Ovintiv to $54, down from $56, while maintaining an Outperform rating. The firm acknowledged Ovintiv’s strategic pause in its share buyback program, aimed at managing debt from the Montney acquisition. Morgan Stanley (NYSE:MS) resumed coverage on Ovintiv with an Overweight rating and set a price target of $57. The firm’s analysts highlighted the Montney acquisition’s positive impact on future free cash flow per share.

BMO Capital Markets upgraded Ovintiv’s stock rating from Market Perform to Outperform, citing the company’s streamlined portfolio and operational performance in the Midland and Montney regions. The analyst noted Ovintiv’s clear path toward continued debt reduction, with plans to resume share buybacks in the second quarter of the year. These developments reflect a positive outlook on Ovintiv’s financial strategy and potential for investor returns.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.